Published in Crit Care Med on July 01, 1997
Update on meningococcal disease with emphasis on pathogenesis and clinical management. Clin Microbiol Rev (2000) 3.69
Monitoring immune dysfunctions in the septic patient: a new skin for the old ceremony. Mol Med (2008) 2.93
IL-7 promotes T cell viability, trafficking, and functionality and improves survival in sepsis. J Immunol (2010) 2.29
Sepsis-induced human lymphocyte apoptosis and cytokine production in "humanized" mice. J Leukoc Biol (2009) 2.27
Molecular characterization of the acute inflammatory response to infections with gram-negative versus gram-positive bacteria. Infect Immun (2003) 1.75
Cytokines in sepsis: potent immunoregulators and potential therapeutic targets--an updated view. Mediators Inflamm (2013) 1.54
Hospitalized cancer patients with severe sepsis: analysis of incidence, mortality, and associated costs of care. Crit Care (2004) 1.46
Tumor necrosis factor-dependent adhesions as a major protective mechanism early in septic peritonitis in mice. Infect Immun (2001) 1.31
Inactivation of catecholamines by superoxide gives new insights on the pathogenesis of septic shock. Proc Natl Acad Sci U S A (2000) 1.21
Hemodynamic goals in randomized clinical trials in patients with sepsis: a systematic review of the literature. Crit Care (2007) 1.18
Scientific and clinical challenges in sepsis. Curr Pharm Des (2009) 1.14
Targeted delivery of siRNA to cell death proteins in sepsis. Shock (2009) 1.12
Increased distribution and expression of CD64 on blood polymorphonuclear cells from patients with the systemic inflammatory response syndrome (SIRS). Clin Exp Immunol (2001) 1.12
Systemic inflammatory response syndrome (SIRS): where did it come from and is it still relevant today? Virulence (2013) 1.10
Lipopolysaccharide sequestrants: structural correlates of activity and toxicity in novel acylhomospermines. J Med Chem (2005) 1.10
Uptake of apoptotic DC converts immature DC into tolerogenic DC that induce differentiation of Foxp3+ Treg. Eur J Immunol (2010) 1.07
Neutrophils with myeloid derived suppressor function deplete arginine and constrain T cell function in septic shock patients. Crit Care (2014) 1.04
An A2A adenosine receptor agonist, ATL313, reduces inflammation and improves survival in murine sepsis models. BMC Infect Dis (2008) 1.02
Apoptotic dendritic cells induce tolerance in mice through suppression of dendritic cell maturation and induction of antigen-specific regulatory T cells. J Immunol (2009) 1.02
Bound to shock: protection from lethal endotoxemic shock by a novel, nontoxic, alkylpolyamine lipopolysaccharide sequestrant. Antimicrob Agents Chemother (2007) 1.01
Trauma-hemorrhagic shock mesenteric lymph induces endothelial apoptosis that involves both caspase-dependent and caspase-independent mechanisms. Ann Surg (2004) 1.00
Early activation of hepatic NFkappaB and NF-IL6 in polymicrobial sepsis correlates with bacteremia, cytokine expression, and mortality. Ann Surg (1999) 0.99
Gene expression-based classifiers identify Staphylococcus aureus infection in mice and humans. PLoS One (2013) 0.99
Cortistatin, a new antiinflammatory peptide with therapeutic effect on lethal endotoxemia. J Exp Med (2006) 0.98
Farnesyltransferase inhibitor improved survival following endotoxin challenge in mice. Biochem Biophys Res Commun (2009) 0.96
A simple mathematical model of cytokine capture using a hemoadsorption device. Ann Biomed Eng (2008) 0.96
Procalcitonin in preoperative diagnosis of abdominal sepsis. Langenbecks Arch Surg (2007) 0.92
Statins in the critically ill. Ann Intensive Care (2012) 0.90
A brief overview of acute respiratory distress syndrome. World J Surg (2006) 0.90
[Diagnosis and therapy of sepsis]. Clin Res Cardiol (2006) 0.87
Propofol increases morbidity and mortality in a rat model of sepsis. Crit Care (2015) 0.87
Induction of the heat shock response in vivo inhibits NF-kappaB activity and protects murine liver from endotoxemia-induced injury. J Clin Immunol (2005) 0.85
Humanized mice, a new model to study the influence of drug treatment on neonatal sepsis. Infect Immun (2013) 0.84
Experimental validation of a theoretical model of cytokine capture using a hemoadsorption device. Ann Biomed Eng (2009) 0.83
Biomarkers of Endothelial Activation Are Associated with Poor Outcome in Critical Illness. PLoS One (2015) 0.83
Leucocyte response and anti-inflammatory cytokines in community acquired pneumonia. Thorax (2001) 0.82
CRISPLD2 is expressed at low levels during septic shock and is associated with procalcitonin. PLoS One (2013) 0.82
Bench-to-bedside review: Developmental influences on the mechanisms, treatment and outcomes of cardiovascular dysfunction in neonatal versus adult sepsis. Crit Care (2007) 0.82
Trauma is danger. J Transl Med (2011) 0.81
Increasing the efficacy of anti-inflammatory agents used in the treatment of sepsis. Eur J Clin Microbiol Infect Dis (2003) 0.81
Multi-drug strategies are necessary to inhibit the synergistic mechanism causing tissue damage and organ failure in post infectious sequelae. Inflammopharmacology (1999) 0.81
Therapeutic effects of pyrrolidine dithiocarbamate on acute lung injury in rabbits. J Transl Med (2011) 0.80
Methods of monitoring shock. Semin Respir Crit Care Med (2004) 0.80
Antimicrobial peptides for gram-negative sepsis: a case for the polymyxins. Front Immunol (2012) 0.78
Ventilator induced lung injury and infection in the critically ill. Thorax (2001) 0.78
Prevalence of occult adrenal insufficiency and the prognostic value of a short corticotropin stimulation test in patients with septic shock. Indian J Crit Care Med (2009) 0.78
Monocyte Tumor Necrosis Factor-α-Converting Enzyme Catalytic Activity and Substrate Shedding in Sepsis and Noninfectious Systemic Inflammation. Crit Care Med (2015) 0.78
Treatment of Experimental Candida Sepsis with a Janus Kinase Inhibitor Controls Inflammation and Prolongs Survival. Antimicrob Agents Chemother (2015) 0.78
Template-directed dye-terminator incorporation with fluorescence polarization detection for analysis of single nucleotide polymorphisms implicated in sepsis. J Mol Diagn (2002) 0.78
Immune-responsiveness of CD4(+) T cells during Streptococcus suis serotype 2 infection. Sci Rep (2016) 0.77
Treatment of severe sepsis: where next? Current and future treatment approaches after the introduction of drotrecogin alfa. Vasc Health Risk Manag (2006) 0.77
Chloral hydrate-dependent reduction in the peptidoglycan-induced inflammatory macrophage response is associated with lower expression levels of toll-like receptor 2. Exp Ther Med (2014) 0.77
Cecal ligation and puncture-induced impairment of innate immune function does not occur in the absence of caspase-1. J Immunol (2011) 0.76
Endogenous Tetrapyrroles Influence Leukocyte Responses to Lipopolysaccharide in Human Blood: Pre-Clinical Evidence Demonstrating the Anti-Inflammatory Potential of Biliverdin. J Clin Cell Immunol (2014) 0.76
Targeting ADAM17 in leukocytes increases neutrophil recruitment and reduces bacterial spread during polymicrobial sepsis. J Leukoc Biol (2016) 0.76
Update in internal medicine. Arch Med Res (2000) 0.75
Dietary Apigenin Exerts Immune-Regulatory Activity in Vivo by Reducing NF-κB Activity, Halting Leukocyte Infiltration and Restoring Normal Metabolic Function. Int J Mol Sci (2016) 0.75
Emerging infection and sepsis biomarkers: will they change current therapies? Expert Rev Anti Infect Ther (2016) 0.75
Editorial comment. Crit Care (1999) 0.75
Serum macrophage migration inhibitory factor reflects adrenal function in the hypothalamo-pituitary-adrenal axis of septic patients: an observational study. BMC Infect Dis (2009) 0.75
Impact of thrombosis on pulmonary endothelial injury and repair following sepsis. Am J Physiol Lung Cell Mol Physiol (2017) 0.75
Rapid Hemodynamic Deterioration and Death due to Acute Severe Refractory Septic Shock. J Clin Med Res (2009) 0.75
Insight into the beneficial immunomodulatory mechanism of the sevoflurane metabolite hexafluoro-2-propanol in a rat model of endotoxaemia. Clin Exp Immunol (2015) 0.75
Hypothesis: is a failure to prevent bacteriolysis and the synergy among microbial and host-derived pro-inflammatory agonists the main contributory factors to the pathogenesis of post-infectious sequelae? Inflammation (2001) 0.75
Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann Intern Med (1990) 5.15
Infant zygosity can be assigned by parental report questionnaire data. Twin Res (2000) 4.33
Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med (1984) 3.81
Mutations activating the yeast eIF-2 alpha kinase GCN2: isolation of alleles altering the domain related to histidyl-tRNA synthetases. Mol Cell Biol (1992) 2.51
A circulating myocardial depressant substance in humans with septic shock. Septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance. J Clin Invest (1985) 2.26
Markers of the denormalisation of smoking and the tobacco industry. Tob Control (2008) 2.09
Patient-triggered synchronized assisted ventilation of newborns. Report of a preliminary study and three years' experience. J Perinatol (1991) 2.07
Serial cardiovascular variables in survivors and nonsurvivors of human septic shock: heart rate as an early predictor of prognosis. Crit Care Med (1987) 1.89
The coronary circulation in human septic shock. Circulation (1986) 1.83
Does bicarbonate therapy improve the management of severe diabetic ketoacidosis? Crit Care Med (1999) 1.78
Regulating the tobacco retail environment: beyond reducing sales to minors. Tob Control (2009) 1.61
Human Hsp70 molecular chaperone binds two calcium ions within the ATPase domain. Structure (1997) 1.60
A controlled trial of HA-1A in a canine model of gram-negative septic shock. JAMA (1993) 1.59
G-CSF during Escherichia coli versus Staphylococcus aureus pneumonia in rats has fundamentally different and opposite effects. Am J Respir Crit Care Med (1999) 1.58
Thrombotic thrombocytopenic purpura related to ticlopidine. Lancet (1991) 1.58
Short term effect of recombinant tissue plasminogen activator in patients with hemodynamically stable acute pulmonary embolism: results of a meta-analysis involving 464 patients. Thromb Res (2009) 1.46
Response of the septic vasculature to prolonged vasopressor therapy with N(omega)-monomethyl-L-arginine and epinephrine in canines. Crit Care Med (1998) 1.39
Injury to the spinal cord without radiological abnormality (SCIWORA) in adults. J Bone Joint Surg Br (2000) 1.38
On-site physician staffing in a community hospital intensive care unit. Impact on test and procedure use and on patient outcome. JAMA (1984) 1.37
Gram-negative bacteremia produces both severe systolic and diastolic cardiac dysfunction in a canine model that simulates human septic shock. J Clin Invest (1986) 1.34
Antioxidant defenses in the lung. Annu Rev Physiol (1986) 1.32
High sensitivity and specificity of serum procalcitonin levels in adults with bacterial meningitis. Clin Infect Dis (1999) 1.28
The effects of steroids during sepsis depend on dose and severity of illness: an updated meta-analysis. Clin Microbiol Infect (2009) 1.24
Anti-inflammatory therapies in sepsis and septic shock. Expert Opin Investig Drugs (2000) 1.19
Persistence of Pneumocystis carinii in lung tissue of acquired immunodeficiency syndrome patients treated for pneumocystis pneumonia. Am Rev Respir Dis (1984) 1.19
Serum and ascitic procalcitonin levels in cirrhotic patients with spontaneous bacterial peritonitis: diagnostic value and relationship to pro-inflammatory cytokines. Intensive Care Med (2000) 1.19
Cardiopulmonary toxicity after liposomal amphotericin B infusion. Ann Intern Med (1991) 1.17
Platelet-activating factor receptor antagonist BN 52021 in the treatment of severe sepsis: a randomized, double-blind, placebo-controlled, multicenter clinical trial. BN 52021 Sepsis Study Group. Crit Care Med (1994) 1.13
Depressed left ventricular performance. Response to volume infusion in patients with sepsis and septic shock. Chest (1988) 1.09
Topographic organization of the orientation column system in large flat-mounts of the cat visual cortex: a 2-deoxyglucose study. J Comp Neurol (1987) 1.07
Symptomatic inferior vena cava filter thrombosis: clinical study of 30 consecutive cases. Eur Respir J (1996) 1.06
Reliability of palpation of pedal pulses as ascertained by the kappa statistic. J Am Geriatr Soc (1980) 1.06
The third component of complement protects against Escherichia coli endotoxin-induced shock and multiple organ failure. J Exp Med (1994) 1.04
Safeguarding patients in clinical trials with high mortality rates. Am J Respir Crit Care Med (2001) 1.03
The sirens' songs of confirmatory sepsis trials: selection bias and sampling error. Crit Care Med (1998) 1.03
N omega-amino-L-arginine, an inhibitor of nitric oxide synthase, raises vascular resistance but increases mortality rates in awake canines challenged with endotoxin. J Exp Med (1992) 1.01
Tumor necrosis factor challenges in canines: patterns of cardiovascular dysfunction. Am J Physiol (1992) 1.01
Restriction of visual experience to a single orientation affects the organization of orientation columns in cat visual cortex. A study with deoxyglucose. Exp Brain Res (1981) 0.99
The relevance of practice misalignments to trials in transfusion medicine. Vox Sang (2010) 0.98
Death of terminally ill patients on a stretcher in the emergency department: a French speciality? Intensive Care Med (2002) 0.95
TNF but not IL-1 in dogs causes lethal lung injury and multiple organ dysfunction similar to human sepsis. J Appl Physiol (1985) (1991) 0.94
Low exhaled nitric oxide and a polymorphism in the NOS I gene is associated with acute chest syndrome. Am J Respir Crit Care Med (2001) 0.94
Controlled trials of rG-CSF and CD11b-directed MAb during hyperoxia and E. coli pneumonia in rats. J Appl Physiol (1985) (1996) 0.94
Endotoxin in septic shock. Anesth Analg (1993) 0.92
Therapeutic trial of reconstituted human high-density lipoprotein in a canine model of gram-negative septic shock. J Pharmacol Exp Ther (1995) 0.89
The number and distribution of ganglion cells in the retina of the brush-tailed possum, Trichosurus vulpecula. J Comp Neurol (1978) 0.88
Adult first generalized seizure: etiology, biological tests, EEG, CT scan, in an ED. Am J Emerg Med (1995) 0.86
Acute G-CSF therapy is not protective during lethal E. coli sepsis. Am J Physiol Regul Integr Comp Physiol (2001) 0.86
Na,K-ATPase gene transfer mitigates an oxidant-induced decrease of active sodium transport in rat fetal ATII cells. Am J Respir Cell Mol Biol (2001) 0.86
ICAM-1 and CD11b inhibition worsen outcome in rats with E. coli pneumonia. J Appl Physiol (1985) (1999) 0.86
Differential hemodynamic effects of L-NMMA in endotoxemic and normal dogs. Am J Physiol (1995) 0.84
Disseminated intravascular coagulation in Fusobacterium necrophorum septicemia. Scand J Infect Dis (1990) 0.84
Cardiopulmonary effects of granulocyte colony-stimulating factor in a canine model of bacterial sepsis. J Appl Physiol (1985) (1994) 0.84
Acute thrombosis of a vena cava filter with a clot above the filter. Successful treatment with low-dose urokinase. Chest (1994) 0.84
New strategies for combatting sepsis: the magic bullets missed the mark ... but the search continues. Trends Biotechnol (1995) 0.84
rG-CSF reduces endotoxemia and improves survival during E. coli pneumonia. J Appl Physiol (1985) (1997) 0.84
Thyroid function in mongoloid children. Thyroxine-binding capacity. Am J Dis Child (1965) 0.84
Intubation of the trachea in the critical care setting. JAMA (1985) 0.83
Continuous arteriovenous hemofiltration does not improve survival in a canine model of septic shock. J Am Coll Surg (1995) 0.83
Cardiopulmonary effects of inhaled nitric oxide in normal dogs and during E. coli pneumonia and sepsis. J Appl Physiol (1985) (1998) 0.83
Myelin sheath thickness and conduction latency groups in the cat optic nerve. J Comp Neurol (1978) 0.83
The serotonin transporter gene and peer-rated neuroticism. Neuroreport (1997) 0.83
Mammalian cytosolic DnaJ homologues affect the hsp70 chaperone-substrate reaction cycle, but do not interact directly with nascent or newly synthesized proteins. Biochemistry (1998) 0.83
Factors that determine the hemodynamic response to inhalation anesthetics. J Appl Physiol (1985) (1991) 0.83
Inflammation and oxygen free radical formation during pulmonary ischemia-reperfusion injury. J Appl Physiol (1985) (1992) 0.82
Tyrphostin AG 556 improves survival and reduces multiorgan failure in canine Escherichia coli peritonitis. J Clin Invest (1997) 0.82
Resistive Index or color-Doppler semi-quantitative evaluation of renal perfusion by inexperienced physicians: results of a pilot study. Minerva Anestesiol (2014) 0.82
Gene therapy for murine mucopolysaccharidosis type VII. Neuromuscul Disord (1997) 0.81
Increasing the efficacy of anti-inflammatory agents used in the treatment of sepsis. Eur J Clin Microbiol Infect Dis (2003) 0.81
Parvovirus glomerulonephritis in a patient with sickle cell disease. Pediatr Nephrol (1999) 0.81
Organization of parallel projections from Pacinian afferent fibers to somatosensory cortical areas I and II in the cat. J Neurophysiol (1983) 0.81
Therapeutic trial of lipid X in a canine model of septic shock. J Infect Dis (1993) 0.81
Combined family trio and case-control analysis of the COMT Val158Met polymorphism in European patients with anorexia nervosa. Am J Med Genet B Neuropsychiatr Genet (2004) 0.81
Leukocyte CD11b/18 antigen-directed monoclonal antibody improves early survival and decreases hypoxemia in dogs challenged with tumor necrosis factor. Am Rev Respir Dis (1992) 0.81
Transmission disequilibrium analysis of a triplet repeat within the hKCa3 gene using family trios with schizophrenia. Biochem Biophys Res Commun (1998) 0.81
Endotoxaemia in patients with severe sepsis or septic shock. Intensive Care Med (2000) 0.81
Evaluation of the effectiveness of an international diploma course in tropical medicine. J Contin Educ Health Prof (2001) 0.81
[Catheter infection in intensive care: influence of systematic replacement of central venous catheters on a guide wire every 4 days]. Presse Med (1997) 0.80
Systemic hemodynamic abnormalities and vasopressor therapy in sepsis and septic shock. Am J Kidney Dis (1992) 0.80
Role of endotoxemia in cardiovascular dysfunction and lethality: virulent and nonvirulent Escherichia coli challenges in a canine model of septic shock. Infect Immun (1996) 0.80
Clinical surfactant preparations mediate SOD and catalase uptake by type II cells and lung tissue. Am J Physiol (1996) 0.79
Evaluation of colonisation of peripheral venous catheters inserted by prehospital emergency service teams (SMUR) in France. J Hosp Infect (2009) 0.79
Hemodynamic effects of dopamine, norepinephrine, and fluids in a dog model of sepsis. Am J Physiol (1995) 0.79
Fluorescent glucagon derivatives. I. Synthesis and characterisation of fluorescent glucagon derivatives. Biochim Biophys Acta (1988) 0.78
Toxicities with intravenous and subcutaneous administration of a petroleum distillate. Drug Intell Clin Pharm (1981) 0.78
Soluble interleukin-6 receptor in patients with severe sepsis. J Infect Dis (1995) 0.78
Acute hemorrhage in dogs: construction and validation of models to quantify blood loss. J Appl Physiol (1985) (1993) 0.78
Two novel variants in the DOPA decarboxylase gene: association with bipolar affective disorder. Mol Psychiatry (1999) 0.78
[Traumatic rupture of the aorta diagnosed by transesophageal echocardiography. Apropos of a case and review of the literature]. Arch Mal Coeur Vaiss (1994) 0.77
The effect of sympathetic nerve stimulation on responses of cutaneous pacinian corpuscles in the cat. Neurosci Lett (1981) 0.77
Serial measures of total body oxygen consumption in an awake canine model of septic shock. Am J Respir Crit Care Med (1996) 0.77
[Phlebitis following travel]. Presse Med (1993) 0.77
[Dosage adjustment of vancomycin in continuous infusion in critically ill-patients]. Ann Fr Anesth Reanim (2010) 0.77
Deoxyglucose mapping in the cat visual cortex following carotid artery injection and cortical flat-mounting. J Neurosci Methods (1987) 0.76
Local synthesis of tumor necrosis factor-alpha and interleukin-1 in the peritoneal cavity during spontaneous bacterial peritonitis. J Infect Dis (1991) 0.76